Synthetic peptide from the V3 loop consensus motif with a potent anti- HIV activity inhibits ristocetin-mediated vWF-GPIb interaction

Peptides

Volumn 18, Issue 9, 1997, Pages 1289-1293

  Mohri, Hiroshi ^a   Asakura, Yusuke ^a   Fukushima, Jun ^a   Kawamoto, Susumu ^a   Okubo, Takao ^a   Okuda, Kenji ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Glycoprotein Ib; HIV 1 IIIB peptide; Ristocetin; von Willebrand factor

Indexed keywords

ANTIVIRUS AGENT; ARGINYLGLYCYLPROLYLGLYCYLARGINYLALANYLPHENYLVALYLTHREONYL ISOLEUCINE; GLYCOPROTEIN IB; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; MONOCLONAL ANTIBODY RG 46; RISTOCETIN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

AMINO ACID SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; DRUG EFFECT; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; VIRUS CELL INTERACTION; VIRUS INHIBITION;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; ANTI-HIV AGENTS; CONSENSUS SEQUENCE; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; RISTOCETIN; VON WILLEBRAND FACTOR;

EID: 0030669248     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00205-2     Document Type: Article

References (27)

1. Azuma H., Sugimoto M., Ruggeri Z. M., Ware J. A role for von Willebrand factor proline residues 702-704 in ristocetin-mediated binding to platelet glycoprotein Ib. Thromb. Haemost. 69:1993;192-196.
2. + UT-7 megakaryocytic human cell line becomes highly HIV-1 and HIV-2 susceptible upon CXCR4 transfection Induction of cell differentiation by HIV-1 infection . Blood. 89:1997;2670-2678.
3. Berliner S., Niiya K., Roberts J. R., Houghten R. A., Ruggeri Z. M. ; Generation and characterization of peptide-specific antibodies that inhibit von Willebrand factor binding to glycoprotein IIb-IIIa without interacting with other adhesive molecules. J. Biol. Chem. 263:1988;7500-7505.
4. Berndt M. C., Ward C. M., Booth W. J., Castaldi P. A., Mazurov A. V., Andrews R. Identification of aspartic acid-514 through glutamic acid-542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin . Biochemistry. 31:1992;1144-1152.
5. Bolognesi D. P. Human immunodeficiency virus vaccines. Adv. Virus Res. 42:1993;103-148.
6. Bradford M. M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-255.
7. Doranz B. J., Rucker J., Yi Y., Smyth R. J., Samson M., Peiper S. C., Parmentier M., Collman R. G., Doms R. W. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell. 85:1996;1149-1158.
8. Ey P. L., Prowse S. J., Jenkin C. R. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry. 15:1978;429-436.
9. Feng Y., Broder C. C., Kennedy P., Berger E. HIV-1 entry cofactor functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor . Science. 272:1996;872-877.
10. Fracker D. J., Speck J. C. Protein and cell membrane iodinations with a sparingly soluble chloramide 1,3,4,6 tetrachloro 3a,6a diphenyl-glycoluril. Biochem. Biophys. Res. Commun. 80:1978;849-856.
11. Fujimura Y., Titani K., Holland L. Z., Russell S. R., Roberts J. R., Elder J. H., Ruggeri Z. M., Zimmerman T. S. von Willebrand factor. A reduced alkylated 52/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet membrane glycoprotein Ib. J. Biol. Chem. 261:1986;381-385.
12. Fujimura Y., Titani K., Holland L. Z., Roberts J. R., Kostel P., Ruggeri Z. M., Zimmerman T. S. A heparin-binding domain of human von Willebrand factor. Characterization and localization to a tryptic fragment extending from amino acid residue Val-449 to Lys-728. J. Biol. Chem. 262:1987;1734-1739.
13. Gralnick H. R., Williams S., McKeown L., Kramer W., Krutzch H., Gorecki M., Pinet A., Grafinkel L. I. A monomeric von Willebrand factor fragment, Leu-504-Ser-728, inhibits von Willebrand factor interaction with glycoprotein Ib-IX. Proc. Natl. Acad. Sci. USA. 89:1992;7880-7884.
14. Hoylaerts M. F., Nuyts K., Peerlinck K., Deckmyn H., Vermylen J. ; Promotion of binding of von Willebrand factor to platelet glycoprotein Ib by dimers of ristocetin. Biochem. J. 306:1995;453-463.
15. Hwang S. S., Boyle T. J., Lyerly H. K., Cullen B. R. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science. 253:1991;71-74.
16. LaRosa G. J., Davide J. P., Weinhold K., Waterbury J. A., Profy A. T., Lewis J. A., Langlois A. J., Dreesman G. R., Boswell R. N., Sadduck P., Holley L. H., Karplus M., Bolognesi D. P., Matthews T. J., Emini E. A., Putney S. D. Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science. 249:1990;932-935.
17. Loetscher M., Geiser T., O'Reilly T., Zwahlen R., Baggiolini M., Moser B. Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J. Biol. Chem. 289:1994;232-237.
18. Maddon P. J., Dalgleish A. G., McDougal J. S., Clapham P. R., Weiss R. A., Axel R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell. 47:1986;333-348.
19. Mohri H., Tanabe J., Ohtsuka M., Yoshida M., Motomura S., Nishida S., Fujimura Y., Okubo T. Acquired von Willebrand disease associated with multiple myeloma characterization of an inhibitor to von Willebrand factor . Blood Coagul. Fibrin. 6:1995;561-566.
20. Mohri H. Acquired von Willebrand disease and storage pool disease in chronic myelocytic leukemia. Am. J. Hematol. 22:1986;391-401.
21. Mohri H., Fujimura Y., Shima M., Yoshioka A., Hougten R. A., Ruggeri Z. M., Zimmerman T. S. Structure of the von Willebrand factor domain interacting with glycoprotein Ib. J. Biol. Chem. 263:1988;17901-17904.
22. α demonstrating negatively charged residues involved in von Willebrand factor binding. J. Biol. Chem. 266:1991;15474-15480.
23. Nehete P. M., Arlinghaus R. H., Sastry K. J. Inhibition of human immunodeficiency virus type I infection and syncytium formation in human cells by V3 loop synthetic peptides from gp120. J. Virol. 67:1993;6841-6846.
24. Samson M., Labbe O., Mollerau C., Vassart G., Parmentier M. Molecular cloning and functional expression of a new human CC-cytokine receptor gene. Biochemistry. 35:1996;3362-3367.
25. Scott J. P., Montogomery R. R., Retzinger G. S. Dimeric ristocetin flocculates proteins, binds to platelets, and mediates von Willebrand factor-dependent agglutination of platelets. J. Biol. Chem. 266:1991;8149-8155.
26. Shioda T., Levy J. A., Cheng-Mayer C. Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature. 349:1991;167-169.
27. Yahi N., Fantini J., Hirsch I., Chermann J. C. Multibranched V3 peptides inhibit human immunodeficiency virus infection in human lymphocytes and macrophages. J. Virol. 68:1994;5714-5720.